Source: Pharmabiz

Vicore Pharma: Vicore Pharma's digital therapeutic for IPF patients shows nearly 50% anxiety reduction in pilot study

Vicore Pharma Holding AB (publ) ("Vicore") pioneering development of angiotensin II type 2 receptor agonists (ATRAGs), announces positive results for the pilot

Read full article »
Annual Revenue
$ < 1M
Employees
19
Carl-Johan Dalsgaard's photo - CEO of Vicore Pharma

CEO

Carl-Johan Dalsgaard

CEO Approval Rating

87/100

Read more